findmyKOL

Sandhya Khurana, MB, BS

Basic profile

University of Rochester Medical Center

ORCIDNPI
RegionRochester, NY · NortheastSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Sandhya Khurana is a Respiratory physician affiliated with University of Rochester Medical Center. OpenAlex indexes 75 publications with 1,890 citations (h-index 14).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
75publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,890citations

Total citations across indexed works.

14h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

601 Elmwood Ave
Box Med
Rochester, NY 146420001

Telephone

585-275-4861

Registry record last updated 6 Jul 2023.

View the NPPES registry record

Industry payments

3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    66.7%
    Corticosteroid42.2%
    Trelegy Ellipta41%Breo Ellipta19%Breztri Aerosphere15%Budesonide-Formoterol Fumarate7%Symbicort7%Breyna3%Dulera3%Fluticasone Propionate3%Qvar Redihaler3%
    Part D<11 patients
    Leukotriene Receptor Antagonist7.7%
    Montelukast Sodium100%
    Part D27 patients

    + 5 more classes in this area

  • Dermatology

    12.9%
    Interleukin-4 Receptor alpha Antagonist10.7%
    Dupixent Pen65%Dupixent Syringe35%
    Part D<11 patients
    Corticosteroid2.3%
    Methylprednisolone100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    12.5%
    Corticosteroid7.5%
    Prednisone100%
    Part D34 patients
    H2 blocker3.2%
    Famotidine100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)50.4% facility · 49.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”